You are here: Industry Insights > Antibiotics

News List

Gene-editing tool CRISPR repurposed to develop better antibiotics expressbpd
January 15, 2019
The technique, known as Mobile-CRISPRi, allows scientists to screen for antibiotic function in a wide range of pathogenic bacteria
Antibiotics Prescribed for Children More Often at Nonpediatric EDs drugs
January 09, 2019
Most emergency visits by children occur at nonpediatric emergency departments, which have more frequent antibiotic prescribing, according to a study published online Jan. 8 in Pediatrics.....
GARDP, Eisai and Takeda join forces to identify new antibiotics pharmaceutical-technology
December 13, 2018
The Global Antibiotic Research and Development Partnership (GARDP) in Switzerland has partnered with Eisai and Takeda Pharmaceutical in a bid to discover new antibiotics.....
WHO uncovers big variations in antibiotics consumption November 13, 2018
The "WHO Report on Surveillance of Antibiotic Consumption" looked at antibiotic use in 65 countries.
‘Alarming’ percentage of families share leftover antibiotics europeanpharmaceuticalreview
November 05, 2018
A study has found that an alarming number of families share leftover antibiotics between siblings, parents and others not even related to the family…
GSK to hold on to its antibiotics business, but nearly 200 workers will go fiercepharma
October 08, 2018
It has been a tough rollercoaster ride for GlaxoSmithKline’s U.K. manufacturing site in Ulverston. Once slated to get a major biologics plant with hundreds of new jobs, GSK is now closing a part of the plant and laying off nearly 200 workers.
Decibel adds first clinical candidate with Oricula license deal fiercebiotech
September 28, 2018
Decibel just transformed itself into a clinical-stage biotech by licensing a phase 1 candidate from Seattle startup Oricula Therapeutics.
Ammonia filtration key to efficient antibiotics production cphi-online
August 24, 2018
Leading antibiotics manufacturer reduces unacceptable levels of production downtime.
Bugworks Research raises $9M in series A funding biospectrumasia
August 20, 2018
Bugworks' novel bacterial topoisomerase inhibitor (NBTI) is highly effective against a very broad spectrum of multi-drug resistant bacterial pathogens
After Zavante deal, Nabriva is poised to launch two first-in-class antibiotics GlobalData Healthcare
August 20, 2018
On July 24, Nabriva Therapeutics announced the acquisition of Zavante Therapeutics, a biotechnology company developing treatments for the infections that threaten hospitalized patients.

Previous page 1 2 3 4 5 6 7 8 Next page